Results for tag: "Thalomid"

Thalomid is an oncology drug used to treat multiple myeloma, a type of cancer that affects the plasma cells in the bone marrow. It is also used to treat a rare skin condition called erythema nodosum leprosum. Thalomid is a thalidomide derivative, and is a type of immunomodulatory drug. It works by inhibiting the production of tumor necrosis factor-alpha, which is a protein that can cause inflammation and damage to healthy cells. Thalomid is usually taken orally, and is available in capsule form. Thalomid is used in combination with other drugs to treat multiple myeloma, and is also used to treat other types of cancer, such as non-Hodgkin's lymphoma and chronic myelogenous leukemia. It is also used to treat certain autoimmune diseases, such as Crohn's disease and psoriasis. The Thalomid market is highly competitive, with many companies offering their own versions of the drug. Some of the companies in the market include Celgene Corporation, Teva Pharmaceuticals, and Mylan Pharmaceuticals. Show Less Read more